Ian T Bothwell Organicell Regenerative Medicine, Inc. (OCEL) insider trading activity

Ian T Bothwell is Interim CEO & CFO of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 133 Million shares of OCEL, which is worth approximately $153 Million. The most recent transaction as insider was on Oct 29, 2021, when has been sold 15,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133M

0% 3M change

0% 12M change

Total Value Held $153 Million

IAN T BOTHWELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 29 2021	SELL Other acquisition or disposition	-	15,000,000 Reduced 10.13%	133,018,726 Common Stock
Oct 29 2021	BUY Other acquisition or disposition	-	15,000,000 Added 9.2%	148,018,726 Common Stock
Jun 17 2021	SELL Open market or private sale	$7,000 $0.14 p/Share	50,000 Reduced 0.03%	148,018,726 Common Stock
Jun 16 2021	SELL Open market or private sale	$14,400 $0.16 p/Share	90,000 Reduced 0.06%	148,068,726 Common Stock
Jun 15 2021	SELL Open market or private sale	$8,000 $0.16 p/Share	50,000 Reduced 0.03%	148,158,726 Common Stock
Jun 14 2021	SELL Open market or private sale	$7,000 $0.14 p/Share	50,000 Reduced 0.03%	148,208,726 Common Stock
Jun 11 2021	SELL Open market or private sale	$7,000 $0.14 p/Share	50,000 Reduced 0.03%	148,258,726 Common Stock
Jun 10 2021	SELL Open market or private sale	$21,000 $0.14 p/Share	150,000 Reduced 0.1%	148,308,726 Common Stock
Jun 09 2021	SELL Open market or private sale	$12,000 $0.15 p/Share	80,000 Reduced 0.05%	148,458,726 Common Stock
Jun 08 2021	SELL Open market or private sale	$14,000 $0.14 p/Share	100,000 Reduced 0.07%	148,538,726 Common Stock
Jun 07 2021	SELL Open market or private sale	$12,000 $0.12 p/Share	100,000 Reduced 0.07%	148,638,726 Common Stock
Jun 04 2021	SELL Open market or private sale	$14,000 $0.14 p/Share	100,000 Reduced 0.07%	148,738,726 Common Stock
Jun 02 2021	SELL Open market or private sale	$15,300 $0.17 p/Share	90,000 Reduced 0.06%	148,838,726 Common Stock
Jun 01 2021	SELL Open market or private sale	$9,500 $0.19 p/Share	50,000 Reduced 0.03%	148,928,726 Common Stock
May 28 2021	SELL Open market or private sale	$9,000 $0.18 p/Share	50,000 Reduced 0.03%	148,978,726 Common Stock
May 27 2021	SELL Open market or private sale	$18,000 $0.18 p/Share	100,000 Reduced 0.07%	149,028,726 Common Stock
May 26 2021	SELL Open market or private sale	$7,600 $0.19 p/Share	40,000 Reduced 0.03%	149,128,726 Common Stock
May 25 2021	SELL Open market or private sale	$20,000 $0.2 p/Share	100,000 Reduced 0.07%	149,168,726 Common Stock
May 24 2021	SELL Open market or private sale	$9,000 $0.18 p/Share	50,000 Reduced 0.03%	149,268,726 Common Stock
May 21 2021	SELL Open market or private sale	$9,000 $0.18 p/Share	50,000 Reduced 0.03%	149,318,726 Common Stock
May 20 2021	SELL Open market or private sale	$14,492 $0.19 p/Share	76,274 Reduced 0.05%	149,368,726 Common Stock
May 19 2021	SELL Open market or private sale	$16,500 $0.22 p/Share	75,000 Reduced 0.05%	149,445,000 Common Stock
May 18 2021	SELL Open market or private sale	$11,000 $0.22 p/Share	50,000 Reduced 0.03%	149,520,000 Common Stock
May 17 2021	SELL Open market or private sale	$15,750 $0.21 p/Share	75,000 Reduced 0.05%	149,570,000 Common Stock
May 14 2021	SELL Open market or private sale	$12,000 $0.24 p/Share	50,000 Reduced 0.03%	149,645,000 Common Stock

ITB

Ian T Bothwell

Interim CEO & CFO

Miami, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL

Account